# Shore Bancshares Inc: financial statements, quarterly

SHBI · Nasdaq · CIK 1035092 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/shbi.md) · [Financials](/companies/shbi/financials.md) · [Filings](/companies/shbi/filings.md) · [Insiders](/companies/shbi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/shbi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6.3](/filings/0001628280-24-046326.md) | [4.9 d](/filings/0001035092-26-000014.md) | [4.7](/filings/0001628280-25-023712.md) | [5.3](/filings/0001035092-25-000015.md) | [4.7](/filings/0001035092-25-000022.md) | [6.2 d](/filings/0001035092-26-000014.md) | [4.8](/filings/0001035092-26-000030.md) | [5.8](/filings/0001035092-26-000046.md) | [5.1](/filings/0001035092-25-000022.md) | [5.4 d](/filings/0001035092-26-000014.md) | [5.4](/filings/0001035092-26-000030.md) | [6.0](/filings/0001035092-26-000046.md) |
| Interest expense | $m | [25.6](/filings/0001628280-23-042600.md) | [29.6 d](/filings/0001628280-24-011336.md) | [30.0](/filings/0001628280-24-022329.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(5.0)](/filings/0001628280-24-046326.md) | [4.0 d](/filings/0001035092-26-000014.md) | [2.4](/filings/0001628280-25-023712.md) | [3.8](/filings/0001035092-25-000015.md) | [3.8](/filings/0001035092-25-000022.md) | [4.9 d](/filings/0001035092-26-000014.md) | [4.5](/filings/0001035092-26-000030.md) | [5.1](/filings/0001035092-26-000046.md) | [4.6](/filings/0001035092-25-000022.md) | [4.9 d](/filings/0001035092-26-000014.md) | [5.6](/filings/0001035092-26-000030.md) | [6.3](/filings/0001035092-26-000046.md) |
| Net income | $m | [(9.7)](/filings/0001628280-24-046326.md) | [10.5 d](/filings/0001035092-26-000014.md) | [8.2](/filings/0001035092-25-000022.md) | [11.2](/filings/0001035092-25-000022.md) | [11.2](/filings/0001035092-25-000022.md) | [13.3 d](/filings/0001035092-26-000014.md) | [13.8](/filings/0001035092-26-000046.md) | [15.5](/filings/0001035092-26-000046.md) | [14.3](/filings/0001035092-25-000022.md) | [15.9 d](/filings/0001035092-26-000014.md) | [17.1](/filings/0001035092-26-000046.md) | [18.9](/filings/0001035092-26-000046.md) |
| Diluted EPS | $ per share | [(0.29)](/filings/0001628280-24-046326.md) | not reported | [0.25](/filings/0001628280-25-023712.md) | [0.34](/filings/0001035092-25-000015.md) | [0.34](/filings/0001035092-25-000022.md) | not reported | [0.41](/filings/0001035092-26-000030.md) | [0.46](/filings/0001035092-26-000046.md) | [0.43](/filings/0001035092-25-000022.md) | not reported | [0.51](/filings/0001035092-26-000030.md) | [0.56](/filings/0001035092-26-000046.md) |
| Basic EPS | $ per share | [(0.29)](/filings/0001628280-24-046326.md) | not reported | [0.25](/filings/0001628280-25-023712.md) | [0.34](/filings/0001035092-25-000015.md) | [0.34](/filings/0001035092-25-000022.md) | not reported | [0.41](/filings/0001035092-26-000030.md) | [0.46](/filings/0001035092-26-000046.md) | [0.43](/filings/0001035092-25-000022.md) | not reported | [0.51](/filings/0001035092-26-000030.md) | [0.56](/filings/0001035092-26-000046.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [109](/filings/0001628280-23-042600.md) | [372](/filings/0001628280-25-011575.md) | [115](/filings/0001628280-24-022329.md) | [139](/filings/0001628280-24-036376.md) | [184](/filings/0001628280-24-046326.md) | [460](/filings/0001035092-26-000014.md) | [389](/filings/0001628280-25-023712.md) | [185](/filings/0001035092-25-000015.md) | [417](/filings/0001035092-25-000022.md) | [356](/filings/0001035092-26-000046.md) | [341](/filings/0001035092-26-000030.md) | [258](/filings/0001035092-26-000046.md) |
| Total assets | $m | [5,705](/filings/0001628280-23-042600.md) | [6,011](/filings/0001628280-25-011575.md) | [5,826](/filings/0001628280-24-022329.md) | [5,864](/filings/0001628280-24-036376.md) | [5,918](/filings/0001628280-24-046326.md) | [6,231](/filings/0001035092-26-000014.md) | [6,177](/filings/0001628280-25-023712.md) | [6,038](/filings/0001035092-25-000015.md) | [6,278](/filings/0001035092-25-000022.md) | [6,259](/filings/0001035092-26-000046.md) | [6,206](/filings/0001035092-26-000030.md) | [6,151](/filings/0001035092-26-000046.md) |
| Total liabilities | $m | [5,204](/filings/0001628280-23-042600.md) | [5,500](/filings/0001628280-25-011575.md) | [5,310](/filings/0001628280-24-022329.md) | [5,341](/filings/0001628280-24-036376.md) | [5,384](/filings/0001628280-24-046326.md) | [5,690](/filings/0001035092-26-000014.md) | [5,624](/filings/0001628280-25-023712.md) | [5,473](/filings/0001035092-25-000015.md) | [5,701](/filings/0001035092-25-000022.md) | [5,669](/filings/0001035092-26-000046.md) | [5,603](/filings/0001035092-26-000030.md) | [5,535](/filings/0001035092-26-000046.md) |
| Long-term debt | $m | [72.0](/filings/0001628280-23-042600.md) | [72.7](/filings/0001628280-25-011575.md) | [72.6](/filings/0001628280-24-022329.md) | [123](/filings/0001628280-24-036376.md) | [123](/filings/0001628280-24-046326.md) | [73.7](/filings/0001035092-26-000014.md) | [74.0](/filings/0001628280-25-023712.md) | [74.2](/filings/0001035092-25-000015.md) | [74.5](/filings/0001035092-25-000022.md) | [89.1](/filings/0001035092-26-000046.md) | [89.0](/filings/0001035092-26-000030.md) | [89.2](/filings/0001035092-26-000046.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [502](/filings/0001628280-24-046326.md) | [511](/filings/0001035092-26-000014.md) | [515](/filings/0001035092-25-000022.md) | [523](/filings/0001035092-25-000022.md) | [533](/filings/0001035092-25-000022.md) | [541](/filings/0001035092-26-000046.md) | [552](/filings/0001035092-26-000046.md) | [565](/filings/0001035092-26-000046.md) | [577](/filings/0001035092-25-000022.md) | [590](/filings/0001035092-26-000046.md) | [603](/filings/0001035092-26-000046.md) | [616](/filings/0001035092-26-000046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(24.0) d](/filings/0001628280-24-046326.md) | [36.1 d](/filings/0001035092-26-000014.md) | [2.4](/filings/0001628280-25-023712.md) | [3.0 d](/filings/0001035092-25-000015.md) | [9.1 d](/filings/0001035092-25-000022.md) | [32.4 d](/filings/0001035092-26-000014.md) | [19.8](/filings/0001035092-26-000030.md) | [(8.3) d](/filings/0001035092-26-000046.md) | [42.5 d](/filings/0001035092-25-000022.md) | [8.5 d](/filings/0001035092-26-000014.md) | [31.6](/filings/0001035092-26-000030.md) | [7.6 d](/filings/0001035092-26-000046.md) |
| Capital expenditure | $m | [1.9 d](/filings/0001628280-24-046326.md) | [2.3 d](/filings/0001035092-26-000014.md) | [1.8](/filings/0001628280-25-023712.md) | [1.6 d](/filings/0001035092-25-000015.md) | [0.6 d](/filings/0001035092-25-000022.md) | [1.3 d](/filings/0001035092-26-000014.md) | [1.0](/filings/0001035092-26-000030.md) | [0.9 d](/filings/0001035092-26-000046.md) | [0.6 d](/filings/0001035092-25-000022.md) | [0.7 d](/filings/0001035092-26-000014.md) | [1.1](/filings/0001035092-26-000030.md) | [0.6 d](/filings/0001035092-26-000046.md) |
| Dividends paid | $m | [4.0 d](/filings/0001628280-24-046326.md) | [4.0 d](/filings/0001035092-26-000014.md) | [4.0](/filings/0001628280-25-023712.md) | [4.0 d](/filings/0001035092-25-000015.md) | [4.0 d](/filings/0001035092-25-000022.md) | [4.0 d](/filings/0001035092-26-000014.md) | [4.0](/filings/0001035092-26-000030.md) | [4.0 d](/filings/0001035092-26-000046.md) | [4.1 d](/filings/0001035092-25-000022.md) | [4.0 d](/filings/0001035092-26-000014.md) | [4.0](/filings/0001035092-26-000030.md) | [4.7 d](/filings/0001035092-26-000046.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.9](/filings/0001628280-23-042600.md) | [19.9](/filings/0001628280-24-022329.md) | [19.9](/filings/0001628280-24-036376.md) | [33.1](/filings/0001628280-24-046326.md) | [33.2](/filings/0001628280-25-023712.md) | [33.2](/filings/0001035092-25-000015.md) | [33.3](/filings/0001035092-25-000022.md) | [33.4](/filings/0001035092-26-000030.md) | [33.4](/filings/0001035092-26-000046.md) | [33.4](/filings/0001035092-25-000022.md) | [33.4](/filings/0001035092-26-000030.md) | [33.5](/filings/0001035092-26-000046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,372,276 at 2026-07-30, from the cover of the [10-Q filed 2026-08-03](/filings/0001035092-26-000046.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.